TTM
$507M
YoY change
+53.4%
5Y CAGR
+55.9%
Peak year (FY2025)
$474M
Cumulative operating income
$898M
Operating Income history chart for Insulet (PODD) from 2016 to 2025
Latest: $474M
Operating Income growth chart for Insulet (PODD) from 2016 to 2025
Latest: +53.4%
Operating Income history table for Insulet (PODD) from 2002 to 2025
| FY2025 | $474M | +53.4% | +$165M | ||
| FY2024 | $309M | +40.4% | +$88.9M | ||
| FY2023 | $220M | +485.1% | +$182M | ||
| FY2022 | $37.6M | -70.2% | -$88.4M | ||
| FY2021 | $126M | +144.7% | +$74.5M | ||
| FY2020 | $51.5M | +3.0% | +$1.5M | ||
| FY2019 | $50M | +82.5% | +$22.6M | ||
| FY2018 | $27.4M | -470.3% | +$34.8M | ||
| FY2017 | -$7.4M | -30.9% | +$3.3M | ||
| FY2016 | -$10.7M | -78.0% | +$38M | ||
| FY2015 | -$48.7M | +449.2% | -$39.9M | ||
| FY2014 | -$8.87M | -69.5% | +$20.3M | ||
| FY2013 | -$29.1M | -19.0% | +$6.84M | ||
| FY2012 | -$36M | -15.3% | +$6.5M | ||
| FY2011 | -$42.5M | +9.9% | -$3.83M | ||
| FY2010 | -$38.6M | -34.9% | +$20.7M | ||
| FY2009 | -$59.4M | -33.6% | +$30M | ||
| FY2008 | -$89.3M | +65.9% | -$35.5M | ||
| FY2007 | -$53.8M | +55.4% | -$19.2M | ||
| FY2006 | -$34.6M | +61.1% | -$13.1M | ||
| FY2005 | -$21.5M | +51.9% | -$7.35M | ||
| FY2004 | -$14.2M | +17.8% | -$2.14M | ||
| FY2003 | -$12M | -5.2% | +$658K | ||
| FY2002 | -$12.7M | — | — |
- FY2025$474M+53.4%
- FY2024$309M+40.4%
- FY2023$220M+485.1%
- FY2022$37.6M-70.2%
- FY2021$126M+144.7%
- FY2020$51.5M+3.0%
- FY2019$50M+82.5%
- FY2018$27.4M-470.3%
- FY2017-$7.4M-30.9%
- FY2016-$10.7M-78.0%
- FY2015-$48.7M+449.2%
- FY2014-$8.87M-69.5%
- FY2013-$29.1M-19.0%
- FY2012-$36M-15.3%
- FY2011-$42.5M+9.9%
- FY2010-$38.6M-34.9%
- FY2009-$59.4M-33.6%
- FY2008-$89.3M+65.9%
- FY2007-$53.8M+55.4%
- FY2006-$34.6M+61.1%
- FY2005-$21.5M+51.9%
- FY2004-$14.2M+17.8%
- FY2003-$12M-5.2%
- FY2002-$12.7M—
Operating Income values are taken from Insulet's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Operating Income at Insulet (PODD)
According to Insulet's latest reported financial statements, the company's current operating income (TTM) is $507M. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Insulet (PODD) most recent annual operating income stands at $474M (2025) – surged 53.4% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Insulet operating income compounded at +55.9% per year, sustaining 3 straight years of year-over-year growth.
2025 marks the peak operating income at $474M, with the historical low of -$89.3M recorded in 2008.
Insulet Operating Income by Year
Insulet Operating Income 2025: $474M
Insulet posted operating income of $474M in 2025, surged 53.4% from 2024. This figure represents the highest annual value in the available history.
Insulet Operating Income 2024: $309M
In 2024, Insulet reported operating income of $309M, surged 40.4% from 2023.
Insulet Operating Income 2023: $220M
Insulet operating income in 2023 was $220M, surged 485.1% from 2022.
Insulet Operating Income 2022: $37.6M
2022's operating income for Insulet came in at $37.6M, plunged 70.2% below 2021.
Insulet Operating Income 2021: $126M
Insulet operating income in 2021 was $126M.
See more financial history for Insulet (PODD).
Sector peers by Operating Income
Healthcare peers of Insulet (PODD), ranked by their latest operating income
| $29.7B | |
| $25.6B | |
| $23.5B | |
| $20.1B | |
| $19.9B | |
| $19B | |
| $10.7B | |
| $8.11B |
- $29.7B
- $25.6B
- $23.5B
- $20.1B
- $19.9B
- $10.7B
Frequently asked questions
Insulet (PODD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.